Article Details
-
Event Date
Jul 17, 2019
Welcome. We would be delighted to have you with us in Regensburg and participate in our LIT Symposium 2019.
Title: Synthetic immunology and environment-adapted redirection of T cells
The LIT was established to study T-cell reprogramming in diseased tissues and to develop environment-smart immune-cell therapies against cancer and autoimmune disorders using synthetic biology approaches. In this context, we seek to bring together leading experts from around the world to discuss and design concepts for the future of synthetic immune-cell therapy.
The aim of our LIT Symposium is to explore which programs in immune cells critically shape tissue function in health and disease, which functionalities immune cells need to cure diseased tissues, and how immune cells can be engineered to acquire this desired functionality. We would be delighted to have you with us in Regensburg and participate in our LIT Symposium.
On behalf of the Board of Directors:
Hinrich Abken
Philipp Beckhove
Matthias Edinger
Markus Feuerer
